Stock Screener App

Frei -

Installieren

499.73

0.31% -1.54

United Therapeutics Corp (UTHR)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt UTHR? Forum Prognose Aktiensplit

United Therapeutics Corp Aktie (UTHR) Neueste Nachrichten

United Therapeutics CEO Martine Rothblatt sells $4.79m in stock - Investing.com

United Therapeutics CEO Martine Rothblatt sells $4.79m in stock By Investing.com - Investing.com Nigeria

United Therapeutics (UTHR) CEO Rothblatt exercises 9,500 options and sells 9,500 shares via 10b5-1 plan - Stock Titan

United Therapeutics CEO Rothblatt sells $4.89m in stock - Investing.com

Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock - marketbeat.com

United Therapeutics (UTHR) Stock Looks Undervalued Despite Fresh NDA Filings - simplywall.st

United Therapeutics (NASDAQ:UTHR): A Peter Lynch-Style GARP Play - ChartMill

United Therapeutics Corp (UTHR) CEO trades 9,500 shares after option exercise - Stock Titan

UNITED THERAPEUTICS CORP (UTHR.MX) Analyst insights, Price targets and Recommendations - Yahoo Finance UK

United Therapeutics Corp (UTHR) CEO’s trust sells 9,500 shares under 10b5-1 plan - Stock Titan

United Therapeutics chairperson & CEO sells $5.05m in stock By Investing.com - Investing.com Australia

United Therapeutics (UTHR) CEO trades 9,500 shares under 10b5-1 plan - Stock Titan

United Therapeutics chairperson & CEO sells $5.05m in stock - Investing.com

Baylor College of Medicine strikes multimillion-dollar deal with United Therapeutics for transplant center - The Business Journals

United Therapeutics (UTHR) CEO trades 9,500 shares under 10b5-1 option plan - Stock Titan

Assenagon Asset Management S.A. Purchases 37,355 Shares of United Therapeutics Corporation $UTHR - marketbeat.com

United Therapeutics (UTHR) CEO sells 9,500 shares after option exercise - Stock Titan

United Therapeutics (NASDAQ:UTHR) Sees Strong Trading VolumeShould You Buy? - MarketBeat

United Therapeutics EVP & general counsel Mahon sells $4.29m in shares - Investing.com South Africa

United Therapeutics Corporation $UTHR Shares Sold by Bank of America Corp DE - marketbeat.com

United Therapeutics (NASDAQ:UTHR) CEO Sells 9,500 Shares of Stock - MarketBeat

United Therapeutics Balances Tyvaso Woes With Pipeline Wins - The Globe and Mail

United Therapeutics (UTHR) counsel exercises options, sells 8,300 shares - Stock Titan

United Therapeutics Corp (UTHR) CEO sells 9,500 shares under 10b5-1 plan - Stock Titan

Royal Bank Of Canada Has Lowered Expectations for United Therapeutics (NASDAQ:UTHR) Stock Price - marketbeat.com

United Therapeutics Q2 Earnings Beat Estimates, Revenues Miss Mark - Yahoo Finance

United Therapeutics Corp (UTHR) (Q2 2026) Earnings Call Highligh - GuruFocus

United Therapeutics Corporation Q2 2026 Earnings Call Summary - Yahoo Finance

BofA cuts United Therapeutics stock price target on Tyvaso sales - Investing.com

United Therapeutics Corp (UTHR) (Q2 2026) Earnings Call Highlights: Strong Pipeline Progress ... - Yahoo Finance

MannKind Stock Plummets After Partner United Therapeutics Unveils New ‘Category Killer Product’ - Stocktwits

United Therapeutics Q2 Earnings Call Highlights - MarketBeat

United Therapeutics Corporation (UTHR) options chain - Yahoo Finance Australia

United Therapeutics (NASDAQ:UTHR) Announces Earnings Results - MarketBeat

Earnings call transcript: United Therapeutics posts Q2 2026 EPS beat, revenue miss - Investing.com

United Therapeutics Q2 2026 slides: pipeline advances amid revenue headwinds - Investing.com

United Therapeutics (UTHR) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance

Is United Therapeutics Corp (UTHR) Overvalued After Q2 Earnings - GuruFocus

United Therapeutics (UTHR) Q2 Earnings Surpass Estimates - Yahoo Finance

United Therapeutics (NASDAQ:UTHR) Surprises With Q2 CY2026 Sales - Yahoo Finance

United Therapeutics 2026: Revenue $783.3M, EPS $7.27— 10-Q Summary - TradingView

United Therapeutics: Q2 Earnings Snapshot - Barchart.com

United Therapeutics (UTHR) lifts Q2 EPS, details $2.0B share buyback plan - Stock Titan

Net income $607.9M and $1.5B buyback at United Therapeutics (NASDAQ: UTHR) - Stock Titan

United Therapeutics Corporation Reports Second Quarter 2026 Financial Results - Yahoo Finance

United Therapeutics (NASDAQ:UTHR) CEO Sells $4,902,570.00 in Stock - MarketBeat

United Therapeutics (NASDAQ: UTHR) CEO sells 9,500 shares after option exercise - Stock Titan

United Therapeutics earnings on deck after first-quarter miss By Investing.com - Investing.com Nigeria

United Therapeutics earnings on deck after first-quarter miss - Investing.com

Earnings To Watch: United Therapeutics (UTHR) Reports Q2 Results Tomorrow - StockStory

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 28% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews

United Therapeutics Corp (UTHR) CEO sells 9,500 shares under plan - Stock Titan

Amundi Sells 15,595 Shares of United Therapeutics Corporation $UTHR - MarketBeat

The Manufacturers Life Insurance Company Sells 5,339 Shares of United Therapeutics Corporation $UTHR - marketbeat.com

United Therapeutics (UTHR) CEO trusts exercise options, sell 9,500 shares - Stock Titan

United Therapeutics (NASDAQ:UTHR) CEO Sells 9,500 Shares - marketbeat.com

Investigational Oral PAH Drug Cuts Clinical Worsening Risk 55% - Stock Titan

United Therapeutics Corp (UTHR) CEO trades 9,500 shares in option exercise - Stock Titan

United Therapeutics Corp (UTHR) Valuation: PE, PB & Fair Value Analysis - TradingKey

United Therapeutics CEO Rothblatt sells $5 million in shares - Investing.com

United Therapeutics (UTHR) CEO exercises options, sells 9,500 shares - Stock Titan

Form 4 United Therapeutics Corporation For: 27 July By Investing.com - Investing.com Canada

VTRS

$16.23

1.18%

NBIX

$152.72

1.26%

ZTS

$73.79

2.70%

ELAN

$23.67

5.15%

RDY

$12.27

1.21%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters